Faouzi Djebbari (F Djebbari)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 21

Top Venues

British journal of haematology

European journal of haematology

PloS one

Hematology (Amsterdam, Netherlands)

This page only lists publications with an associated author ORCID identifier.

Publications

Faouzi Djebbari, Alexandros Rampotas, Grant Vallance, Fotios P Panitsas, Nanda Basker, Gina Sangha, Beena Salhan, Farheen Karim, Firas Al-Kaisi, Amy Gudger, Loretta Ngu, Matt Poynton, Ho Pui Jeff Lam, Lowri Morgan, Laura Yang, Jennifer Young, Mairi Walker, Ismini Tsagkaraki, Laura Anderson, Saleena Rani Chauhan, Rebecca Maddams, Richard L Soutar, Margarita Triantafillou, Steve Prideaux, Abubaker Obeidalla, Toby Andrew Eyre, Ceri A Bygrave, Jaimal Kothari, Supratik Basu, Karthik Ramasamy
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients. British journal of haematology (2023)
Faouzi Djebbari, Matt Poynton, Gina Sangha, Laura Anderson, Rebecca Maddams, Toby A Eyre, Grant Vallance, Supratik Basu, Karthik Ramasamy
Outcomes of anti-CD38 isatuximab plus pomalidomide and dexamethasone in five relapsed myeloma patients with prior exposure to anti-C38 daratumumab: case series. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Edmund Watson, Faouzi Djebbari, Alexandros Rampotas, Karthik Ramasamy
BCMA-targeted therapies for multiple myeloma: strategies to maximize efficacy and minimize adverse events. Expert review of hematology 15 (6) (2022)
Faouzi Djebbari, Alexandros Rampotas, Grant Vallance, Fotios Panitsas, Nanda Basker, Gina Sangha, Beena Salhan, Farheen Karim, Al-Kaisi Firas, Amy Gudger, Loretta Ngu, Matt Poynton, Ho Pui Jeff Lam, Lowri Morgan, Laura Yang, Jennifer Young, Mairi Walker, Ismini Tsagkaraki, Laura Anderson, Saleena Rani Chauhan, Rebecca Maddams, Richard Soutar, Margarita Triantafillou, Steve Prideaux, Abubaker Obeidalla, Toby A Eyre, Ceri Bygrave, Supratik Basu, Karthik Ramasamy
Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Faouzi Djebbari, Alexandros Rampotas, Fotios Panitsas, Wen Yuen Lim, Charlotte Lees, Ismini Tsagkaraki, Ana Rita Gomes, Steve Prideaux, Lucia Chen, Catherine Prodger, Akhil Khera, Nicola Gray, Lauren Ellis, Gina Sangha, Toby A Eyre, Sally Moore, Jaimal Kothari, Karthik Ramasamy
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients. PloS one 17 (1) (2022)
Alexandros Rampotas, Faouzi Djebbari, Fotios Panitsas, Charlotte Lees, Ismini Tsagkaraki, Ana Rita Gomes, Steve Prideaux, Lucia Chen, Catherine Prodger, Akhil Khera, Nicola Gray, Lauren Ellis, Gavinda Sangha, Wen Yuen Lim, Toby A Eyre, Sally Moore, Karthik Ramasamy, Jaimal Kothari
Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients. European journal of haematology 106 (4) (2021)
Faouzi Djebbari, Fotios Panitsas, Faye A Sharpley, Alexandros Rampotas, Jemma Larham, Sally Moore, Sarah Gooding, Jaimal Kothari, Karthik Ramasamy
Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes. European journal of haematology 105 (5) (2020)
Faouzi Djebbari, Kanchana De Abrew, Beena Salhan, Fotios Panitsas, Md Imran Hossain, Toby Andrew Eyre, John Willan, Karthik Ramasamy, Supratik Basu, Matthew Jenner, Jaimal Kothari
DPACE-based chemotherapy in the era of myeloma novel agents: A UK multicentre study. European journal of haematology 105 (2) (2020)
Faouzi Djebbari, Faye A Sharpley, Susan McLain-Smith, Grant D Vallance, Toby A Eyre, Jaimal Kothari, Sally Moore, Karthik Ramasamy
Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients. PloS one 15 (2) (2020)
Faye A Sharpley, Jemma Larham, Angus Haines, Faouzi Djebbari, Bing Tseu, Heather Leary, Grant Vallance, Fotios P Panitsas, Lisa Ferguson, Pamela Roberts, Andrew Peniket, Sarah Gooding, Jaimal Kothari, Sally Moore, Karthik Ramasamy
Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK). British journal of haematology 192 (6) (2020)
John Willan, Andrew J King, Faouzi Djebbari, Gareth D H Turner, Daniel J Royston, Sue Pavord, Graham P Collins, Andy Peniket
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic. British journal of haematology 189 (6) (2020)
Faouzi Djebbari, Furqaan Kaji, Louise Stanton, Megan M Lawrence, Graham P Collins, Toby A Eyre
Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma. European journal of haematology 105 (5) (2020)
Faye A Sharpley, Faouzi Djebbari, Samih Fourali, Jaimal Kothari, John A Lynes, Susan McLain-Smith, Karthik Ramasamy
Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM-020) for transplant-ineligible patients with newly-diagnosed multiple myeloma. Leukemia & lymphoma 61 (3) (2019)
Faouzi Djebbari, Maciej Tatarczuch, Fotios Panitsas, Grant Vallance, Manuela Sultanova, Jaimal Kothari, Karthik Ramasamy, Andy Peniket
Resource implications of bortezomib therapy in a large UK cohort: An evaluation study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (8) (2019)
Toby Andrew Eyre, N Martinez-Calle, C Hildyard, D W Eyre, H Plaschkes, J Griffith, J Wolf, P Fields, A Gunawan, R Oliver, Faouzi Djebbari, S Booth, A McMillan, C P Fox, M J Bishton, G P Collins, C S R Hatton
Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age. Journal of internal medicine 285 (6) (2019)
Faouzi Djebbari, Joseph A Browning, Louise Stanton, Stephen Booth, Catherine Hildyard, John Willan, Jenny Bosworth, Sona M Vora, Chris S R Hatton, Graham P Collins, Toby Andrew Eyre
Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphoma. British journal of haematology 186 (6) (2019)
Akhil Khera, Fotios P Panitsas, Faouzi Djebbari, Katja Kimberger, Simon Stern, John Quinn, Neil Rabin, Jaimal Kothari, Bassam Alchi, Richard Haynes, Christopher Winearls, Ian Roberts, Karthik Ramasamy
Long term outcomes in monoclonal gammopathy of renal significance. British journal of haematology 186 (5) (2019)
Faouzi Djebbari, Huben Hubenov, Pratap Neelakantan, Julia Wolf, Mark Offer, Akhil Khera, Eleni Louka, Grant Vallance, Jaimal Kothari, Sally Moore, Karthik Ramasamy
Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience. British journal of haematology 188 (4) (2019)
Faouzi Djebbari, Anandagopal Srinivasan, Grant Vallance, Sally Moore, Jaimal Kothari, Karthik Ramasamy
Clinical outcomes of bortezomib-based therapy in myeloma. PloS one 13 (12) (2018)
Faouzi Djebbari, Nicola Stoner, Verna Teresa Lavender
A systematic review of non-standard dosing of oral anticancer therapies. BMC cancer 18 (1) (2018)
Faouzi Djebbari, Nicola Stoner, Verna Lavender
Non-conventional dosing of oral anticancer agents in oncology and malignant haematology: a systematic review protocol. Systematic reviews 6 (1) (2017)

Faouzi Djebbari.css-eqlu8i{font-size:small;padding-left:4px;} (F Djebbari)

Publication Activity (10 Years)

Top Topics

Top Venues

Faouzi Djebbari (F Djebbari)